Literature DB >> 7152706

Hepatic microsomal enzyme function in technicians and anesthesiologists exposed to halothane and nitrous oxide.

M Døssing, P Weihe.   

Abstract

It is controversial whether daily occupational exposure to halothane stimulates (induces) the hepatic microsomal enzyme function in man. We investigated two groups of persons with different degrees of exposure to halothane: Six technicians who for years had been employed with repair and control of anesthesiologic equipment resulting in exposure to about 7 ppm of halothane and 50 ppm of nitrous oxide, and seven anesthesiologists exposed during months to about 2 ppm of halothane and 75 ppm of nitrous oxide. The clearance of antipyrine was determined from saliva concentrations before and 4 wk after discontinuation of exposure. Matched control persons were investigated simultaneously. No significant differences were found between the half-life, apparent volume of distribution, or clearance of antipyrine either within the groups or between the groups. If the antipyrine data from both exposure groups are compared to those of the control groups, the data exclude (95% confidence limit) that antipyrine metabolism increased by more than 3% during exposure to waste anesthetics. This indicates that occupational exposure to halothane in concentrations above the proposed maximal time weighted average concentration of 2 ppm does not change the microsomal activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7152706     DOI: 10.1007/bf00378414

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  24 in total

1.  The antipyrine test in clinical pharmacology: conceptions and misconceptions.

Authors:  E S Vesell
Journal:  Clin Pharmacol Ther       Date:  1979-09       Impact factor: 6.875

2.  A possible interaction of PCB and halothane in man.

Authors:  H L Zauder
Journal:  Anesthesiology       Date:  1979-07       Impact factor: 7.892

3.  Two compartment analysis of plasma elimination of phenazone in normals and in patients with cirrhosis of the liver.

Authors:  G Greisen; P B Andreasen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-01

Review 4.  Factors causing differences in halothane biotransformation.

Authors:  H F Cascorbi
Journal:  Int Anesthesiol Clin       Date:  1974

5.  Concentration and elimination of anaesthetic gases in recovery rooms.

Authors:  O Berner
Journal:  Acta Anaesthesiol Scand       Date:  1978       Impact factor: 2.105

6.  Increased bishydroxycoumarin requirements in patients receiving phenobarbital.

Authors:  J E Goss; D W Dickhaus
Journal:  N Engl J Med       Date:  1965-11-11       Impact factor: 91.245

7.  Relationship of concentrations of halothane and enflurane to their metabolism and elimination in man.

Authors:  M K Cahalan; B H Johnson; E I Edger
Journal:  Anesthesiology       Date:  1981-01       Impact factor: 7.892

8.  An animal model of hepatotoxicity associated with halothane anesthesia.

Authors:  I G Sipes; B R Brown
Journal:  Anesthesiology       Date:  1976-12       Impact factor: 7.892

9.  Differential induction of antipyrine metabolism by rifampicin.

Authors:  E L Toverud; A R Boobis; M J Brodie; S Murray; P N Bennett; V Whitmarsh; D S Davies
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Changes in cortisol metabolism following rifampicin therapy.

Authors:  O M Edwards; R J Courtenay-Evans; J M Galley; J Hunter; A D Tait
Journal:  Lancet       Date:  1974-09-07       Impact factor: 79.321

View more
  3 in total

1.  Neuropsychological symptoms and occupational exposure to anaesthetics.

Authors:  M J Saurel-Cubizolles; M Estryn-Behar; M F Maillard; N Mugnier; A Masson; G Monod
Journal:  Br J Ind Med       Date:  1992-04

Review 2.  Occupational liver injury. Present state of knowledge and future perspective.

Authors:  M Døssing; P Skinhøj
Journal:  Int Arch Occup Environ Health       Date:  1985       Impact factor: 3.015

Review 3.  Noninvasive assessment of microsomal enzyme activity in occupational medicine: present state of knowledge and future perspectives.

Authors:  M Døssing
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.